Hyponatremia: From physiopathology to practice;Hyponatrémie: De la physiopathologie à la pratique

Revue de Medecine Interne

Volumn 31, Issue 4, 2010, Pages 277-286

  Passeron, A ^a   Dupeux, S ^a,b   Blanchard, A ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Antidiuretic hormone; Hyponatremia; Vasopressin; Vasopressin receptor antagonist

Indexed keywords

FUROSEMIDE; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT; VASOPRESSIN;

BRAIN DAMAGE; CEREBRAL SALT WASTING; DEHYDRATION; DEMYELINATION; EXTRACELLULAR SPACE; HUMAN; HYPONATREMIA; HYPOTHYROIDISM; HYPOVOLEMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTERSTITIAL NEPHRITIS; MUSCLE HYPOTONIA; NATRIURESIS; OSMOREGULATION; PATHOPHYSIOLOGY; SHORT SURVEY; WATER DEPRIVATION;

HUMANS; HYPONATREMIA;

EID: 77950629574     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2009.03.369     Document Type: Short Survey

References (54)

1. Adrogue H.J., Madias N.E., Hyponatremia N Engl J Med 2000, 342:1581-1589.
2. Terzian C., Frye E.B., Piotrowski Z.H. Admission hyponatremia in the elderly: factors influencing prognosis. J Gen Intern Med 1994, 9:89-91.
3. Upadhyay A., Jaber B.L., Madias N.E. Incidence and prevalence of hyponatremia. Am J Med 2006, 119(Suppl. 1):S30-S35.
4. Lee C.T., Guo H.R., Chen J.B. Hyponatremia in the emergency department. Am J Emerg Med 2000, 18:264-268.
5. Gennari F.J. Current concepts. Serum osmolality. Uses and limitations. N Engl J Med 1984, 310:102-105.
6. Kugler J.P., Hustead T. Hyponatremia and hypernatremia in the elderly. Am Fam Phys 2000, 61:3623-3630.
7. Klussmann E., Rosenthal W. Role and identification of protein kinase A anchoring proteins in vasopressin-mediated aquaporin-2 translocation. Kidney Int 2001, 60:446-449.
8. Videen J.S., Michaelis T., Pinto P., Ross B.D. Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J Clin Invest 1995, 95:788-793.
9. Lien Y.H., Shapiro J.I., Chan L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. Implications for the pathogenesis of central pontine myelinolysis. J Clin Invest 1991, 88:303-309.
10. Clayton J.A., Le Jeune I.R., Hall I.P. Severe hyponatremia in medical in-patients: aetiology, assessment and outcome. QJM 2006, 99:505-511.
11. Soupart A., Decaux G. Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications. Clin Nephrol 1996, 46:149-169.
12. Ayus J.C., Arieff A.I. Brain damage and postoperative hyponatremia: the role of gender. Neurology 1996, 46:323-328.
13. Knochel J.P. Hypoxia is the cause of brain damage in hyponatremia. J Am Med Assoc 1999, 281:2342-2343.
14. Renneboog B., Musch W., Vandemergel X., Manto M.U., Decaux G. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med 2006, 119:e1-8.
15. Laureno R., Karp B.I. Myelinolysis after correction of hyponatremia. Ann Intern Med 1997, 126:57-62.
16. Brunner J.E., Redmond J.M., Haggar A.M., Kruger D.F., Elias S.B. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: a prospective magnetic resonnance imaging study. Ann Neurol 1990, 27:61-66.
17. Sterns R.H., Cappuccio J.D., Silver S.M., Cohen E.P. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 1994, 4:1522-1530.
18. Oya S., Tsutsumi K., Ueki K., Kirino T. Reinduction of hyponatremia to treat central pontine myelinolysis. Neurology 2001, 57:1931-1932.
19. Adrogue H.J. Consequence of inadequate management of hyponatremia. Am J Nephrol 2005, 25:240-249.
20. Kumar S., Beri T. Sodium. Lancet 1998, 352:220-228.
21. Weisberg L.S. Pseudohyponatremia: a reappraisal. Am J Med. 1989, 86:315-318.
22. Hillier T.A., Abbott R.D., Barrett E.J. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999, 106:399-403.
23. Guglielminotti J., Pernet P., Maury E., Alzieu M., Vaubourdolle M., Guidet B., et al. Osmolar gap hyponatremia in critically ill patients: evidence for the sick cell syndrome?. Crit Care Med 2002, 30:1051-1055.
24. Huda M.S., Boyd A., Skagen K., Wile D., van Heyningen C., Watson I., et al. Investigation and management of severe hyponatremia in a hospital setting. Postgr Med J 2006, 82:216-219.
25. McGee S., Abernethy W.B., Simel D.L. The rational clinical examination. Is this patient hypovolemic?. J Am Med Assoc 1999, 281:1022-1029.
26. Gross C.R., Lindquist R.D., Woolley A.C., Granieri R., Allard K., Webster B. Clinical indicators of dehydration severity in elderly patients. J Emerg Med 1992, 10:267-274.
27. Beck L.H. Hypouricemia in the syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1979, 301:528-530.
28. Fenske W., Störk S., Koschker A.C., Blechschmidt A., Lorenz D., Wortmann S., et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. J Clin Endocrinol Metab 2008, 93:2991-2997.
29. Chung H.M., Kluge R., Schrier R.W., Anderson R.J. Clinical assessment of extracellular fluid volume in hyponatremia. Am J Med 1987, 83:905-908.
30. Sonnenblick M., Friedlander Y., Rosin A.J. Diuretic induced severe hyponatremia: review and analysis of 129 reported patients. Chest 1993, 103:601-606.
31. Chow K.M., Szeto C.C., Wong T.Y., Leung C.B., Li P.K. Risk factors for thiazide-induced hyponatraemia. QJM 2003, 96:911-917.
32. Palmer B.F. Hyponatraemia in neurosurgical patient: syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant 2000, 15:262-268.
33. Chin M.H., Goldman L. Correlates of major complications or death in patients admitted to the hospital with congestive heart failure. Arch Intern Med 1996, 156:1814-1820.
34. Angeli P., Wong F., Watson H., Ginès P. CAPPS Investigators. Hyponatremia in cirrhosis: results of a patient population survey. Hepatology 2006, 44:1535-1542.
35. Diederich S., Franzen N.F., Bahr V., Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. Eur J Endocrinol 2003, 148:609-617.
36. Ellison D.H., Berl T. The syndrome of inappropriate antidiuresis. N Engl J Med 2007, 356:2064-2072.
37. Bartter F.C., Schwartz W.B. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med 1967, 42:790-806.
38. Feldman B.J., Rosenthal S.M., Vargas G.A., Fenwick R.G., Huang E.A., Matsuda-Abedini M., et al. Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 2005, 352:1884-1890.
39. Dundas B., Harris M., Narasimhan M. Psychogenic polydipsia review: etiology, differential, and treatment. Curr Psychiatr Rep 2007, 9:236-241.
40. Stuart C.A., Neelon F.A., Lebovitz H.E. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N Engl J Med. 1980, 303:1078-1082.
41. Sanghvi S.R., Kellerman P.S., Nanovic L. Beer potomania: An unusual cause of hyponatremia at high risk of complications from rapid correction. Am J Kidney Dis 2007, 50:673-680.
42. Noakes T. Fluid replacement during marathon running. Clin J Sport Med. 2003, 13:309-318.
43. Verbalis J.G., Goldsmith S.R., Greenberg A., Schrier R.W., Sterne R.H. Hyponatremia treatment guidelines 2007: Experts panel recommendations. Am J Med 2007, 120:S1-S21.
44. Sterns R.H., Cappucio J.D., Silver S.M., Cohen E.P. Neurologic sequelea after treatment of severe hyponatremia: a multicenter perspective. J Am Soc Nephrol 1994, 4:1522-1530.
45. White M.G., Fetner C.D. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with lithium carbonate. N Engl J Med 1975, 292:390-392.
46. Forrest J.N., Cox M., Hong C., Morrison G., Bia M., Singer I. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1978, 298:178-187.
47. Decaux G., Brimouille S., Genette F., Mockel J. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am J Med 1980, 69:99-106.
48. Thibonnier M., Conarty D.M., Preston J.A., Wilkins P.L., Berti-Mattera L.N., Mattera R. Molecular pharmacology of human vasopressin receptors. Adv Exp Med Biol 1998, 449:251-276.
49. Knepper M.A. Molecular physiology of urinary concentrating mechanism: regulationof aquaporin water channels by vasopressin. Am J physiol 1997, 272:F3-F12.
50. Decaux G., Soupart A., Vassart G. Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 2008, 371:1624-1632.
51. Schrier R.W., Gross P., Gheorghiade M., Berl T., Verbalis J.G., Czerwiec F.S., et al. Tolvaptan, a selective oral Vassopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 2006, 355:2099-2112.
52. Gheorghiade M., Gattis W.A., O'Connor C.M., Adams K.F., Elkayam U., Barbagelata A., et al. For the acute and chronique therapeutic impact of vasopressin antagonist in congestive heart failure (ACTIV in CHF) investigators. Effects of oral tolvaptan, a vasopressin antagonist, in patients hospitalised with worsening heart failure: a randomized controlled trial. J Am Med Assoc 2004, 291:1963-1971.
53. Konstam M.A., Gheorghiade M., Burnett J.C., Grinfeld L., Maggioni A.P., Swedberg K., et al. Efficacy of vasopressin antagonist in heart failure outcome study with Tolvaptan (EVEREST) Investigators. Effect of oral Tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. J Am Med Assoc 2007, 297:1319-1331.
54. Gines P., Wong F., Watson H., Milutinovic S., del Arbol L.R., Olteanu D. HypoCAT Study Investigators. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology 2008, 48:204-213.